pergolide mesylate 0 410.16978 410.605 pergolide methanesulfonate pubmed:31082785 reaxys:5698117 pubmed:6889702 chemspider:43504 kegg.drug:D00502 pubmed:20949429 pubmed:10365192 KEGG DRUG:66104-23-2 CiteXplore:6889702 Reaxys:5698117 pergolide monomesylate pubmed:24134630 pubmed:7562267 pubmed:19801850 pubmed:15591656 pubmed:8748627 SNOMEDCT:108469007 pubmed:14532675 NCIt:C47665 pubmed:15257688 pubmed:12378837 Pergolide mesilate pergolide monomethanesulfonate pubmed:11257938 InChI=1S/C19H26N2S.CH4O3S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21;1-5(2,3)4/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3;1H3,(H,2,3,4)/t13-,16-,18-;/m1./s1 drugbank:DBSALT002445 KEGG DRUG:D00502 ChemIDplus:66104-23-2 pubmed:27301465 UWCVGPLTGZWHGS-ZORIOUSZSA-N chebi_ontology ChEMBL:349814 (8beta)-8-[(methylsulfanyl)methyl]-6-propylergoline methanesulfonate pubmed:12446951 CHEBI:8021 pubmed:15602103 pubmed:23966481 (8beta)-8-[(methylsulfanyl)methyl]-6-propylergolin-6-ium methanesulfonate cas:66104-23-2 CS(=O)(=O)O.[H][C@@]12Cc3cnc4cccc(c34)[C@@]1([H])C[C@@H](CSC)CN2CCC A methanesulfonate salt obtained from pergolide by mixing eqimolar amount of pergolide and methanesulfonic acid. A dopamine D<small>₂</small> receptor agonist which also has D<small>₁</small> and D<small>₂</small> agonist properties, it is used in the management of Parkinson's disease, although it was withdrawn from the U.S. and Canadian markets in 2007 due to an increased risk of cardiac valve dysfunction. CiteXplore:8748627 pubmed:19210262 pubmed:21507864 DrugBank:DB01186 C19H26N2S.CH4O3S Permax pubmed:21324306 (8beta)-8-[(methylsulfanyl)methyl]-6-propylergoline methanesulfonate ionic salt